Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Yongchuntang Group is a prominent Chinese enterprise focused on the health and wellness industry, particularly the deep processing of Ginkgo biloba. Established in 1999 and based in Jining, Shandong, the company integrates research, cultivation, production, and sales of health foods, traditional Chinese medicine, and personal care products. It operates one of the largest ginkgo standardized cultivation bases in China and utilizes advanced extraction technologies to produce high-purity ginkgo flavonoids and lactones. The group is well-known for its direct selling business model, for which it holds an official license from the Chinese Ministry of Commerce. Its product portfolio aims to address cardiovascular health, immune support, and dermatological care through natural, plant-based solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Yongchuntang Group.